Sancilio and Company
Stuart, Florida, United States · Founded 2004
About Sancilio and Company
Sancilio & Company develops, manufactures, and distributes biopharmaceutical products in the United States and internationally. Its cardiovascular health products include OCEAN BLUE PROFESSIONAL OMEGA-3 2100, which is made from fish oils to decrease the risk of arrhythmias. The company also provides dental health products, including LUDENT SODIUM FLUORIDE CHEWABLE TABLETS that provide fluoride to the children; MVC MULTIVITAMIN WITH FLUORIDE CHEWABLE TABLETS, which contain vitamins and minerals; and sodium fluoride drops. In addition, it offers women’s health products, which include Mylk, a multivitamin/mineral/essential fatty acid softgel; and Caltranate, a blend of calcium formulated to control the release of calcium. Further, Sancilio & Company provides pharmaceutical services, such as analytical chemistry, dissolution testing, formulation development, de-formulation studies, HPLC, GC, GC/MS, and LC/MS support, raw material sourcing, contract tablet, capsule, and soft gel production, small-batch contract manufacturing, bottling/packaging, liquid filling of oral liquids, validation, product sales, and distribution and logistical support services. The company was founded in 2004 and is based in Stuart, Florida with additional offices in Ohio and New Jersey.
Company Facts
- Founded: 2004
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $22.2M
- Last round: Series Unknown (Jul 2014)
- Website: sancilio.com
- Phone: 561-847-2302
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sancilio-and-company-2466126 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.